CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 69 enrolled
Drug / intervention
transforaminal lumbar interbody arthrodesisprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02485574
NCT02485574N/ACompleted

Prospective, Observational Study of Anterior Bridging Cage Augmented With Bone Substitute Versus Localized Autobone in Transforaminal Lumbar Interbody Arthrodesis

Zenoss Co, Ltd·interventional·Posted Jun 30, 2015·Updated Dec 8, 2021

In Brief

A clinical study evaluating transforaminal lumbar interbody arthrodesis for Stenosis and Fusion of Spine (Disease). Completed, enrolled 69 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluation for the pattern of bone bridging of patients who undergo transforaminal lumbar interbody arthrodesis, the investigators hypothesize that auto local bone mixed with β-calcium phosphate + hydroxyapatite (OSTEON 2, Genoss) is not inferior to auto local bone only. In addition, the investigators will analyze anterior new bone bridging pattern between anterior bridging cage newly developed and grafted bone in anterior disc space.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 30, 2015
Enrollment StartMar 1, 2015
Primary CompletionApr 1, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 11.0 years ago

Interventions

transforaminal lumbar interbody arthrodesisprocedure

Anterior bridging cages augmented with auto bone plus β-calcium phosphate + hydroxyapatite in right side of disc space and anterior bridging cages augmented with auto bone in left side of disc space in transforaminal lumbar interbody arthrodesis.